Keros Therapeutics (KROS) Current Assets (2019 - 2026)
Keros Therapeutics (KROS) recorded Current Assets of $266.88 million in Q2 2026, down 63.6% from $732.81 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics reported Current Assets of $315.43 million, down 46.4% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 3.3% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $588.89 million in FY2024 (+69.6%), $347.29 million in FY2023 (+21.5%), $285.77 million in FY2022 (+13.7%) and $251.44 million in FY2021 (-6.1%).
- The Q2 2026 figure is the lowest quarterly Current Assets since Q3 2022.
- On a year-over-year basis, Current Assets rose in five of the last seven quarters, with growth averaging 29.2%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 81.3% in Q3 2024, against a decline of 63.6% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Keros Therapeutics | 222.75 Mn | -1.71 Bn | - | 266.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 266.88 Mn |
| Dec 31, 2025 | 315.43 Mn |
| Sep 30, 2025 | 719.31 Mn |
| Jun 30, 2025 | 732.81 Mn |
| Mar 31, 2025 | 759.51 Mn |
| Dec 31, 2024 | 588.89 Mn |
| Sep 30, 2024 | 552.05 Mn |
| Jun 30, 2024 | 432.71 Mn |
| Mar 31, 2024 | 463.13 Mn |
| Dec 31, 2023 | 347.29 Mn |
| Sep 30, 2023 | 304.44 Mn |
| Jun 30, 2023 | 334.31 Mn |
| Mar 31, 2023 | 362.22 Mn |
| Dec 31, 2022 | 285.77 Mn |
| Sep 30, 2022 | 245.88 Mn |
| Jun 30, 2022 | 222.36 Mn |
| Mar 31, 2022 | 231.22 Mn |
| Dec 31, 2021 | 251.44 Mn |
| Sep 30, 2021 | 226.07 Mn |
| Jun 30, 2021 | 241.42 Mn |
API Access
Keros Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();